| Ticker Details |
|
Standard BioTools Inc.
|
| IPO Date: |
March 1, 2011 |
| Sector: |
Healthcare |
| Industry: |
Diagnostics and Research |
| Market Cap: |
$434.56M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.07 | 3.50%
|
| Avg Daily Range (30 D): |
$0.04 | 2.63%
|
| Avg Daily Range (90 D): |
$0.04 | 2.97%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.31M |
| Avg Daily Volume (30 D): |
1.16M |
| Avg Daily Volume (90 D): |
1.47M |
| Trade Size |
| Avg Trade Size (Sh.): |
195 |
| Avg Trade Size (Sh.) (30 D): |
214 |
| Avg Trade Size (Sh.) (90 D): |
224 |
| Institutional Trades |
| Total Institutional Trades: |
123 |
| Avg Institutional Trade: |
$1.86M |
| Avg Institutional Trade (30 D): |
$1.02M |
| Avg Institutional Trade (90 D): |
$3.28M |
| Avg Institutional Trade Volume: |
.99M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$2.87M |
| Avg Closing Trade (30 D): |
$1.02M |
| Avg Closing Trade (90 D): |
$.78M |
| Avg Closing Volume: |
1.54M |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$-.33
|
$-.09
|
$-.09
|
|
Diluted EPS
|
$-.33
|
$-.09
|
$-.09
|
|
Revenue
|
$169.74M
|
$19.55M
|
$21.76M
|
|
Gross Profit
|
$81.9M
|
$9.48M
|
$10.63M
|
|
Net Income / Loss
|
$-128.25M
|
$-34.69M
|
$-33.46M
|
|
Operating Income / Loss
|
$-159.44M
|
$-32.94M
|
$-25.7M
|
|
Cost of Revenue
|
$87.84M
|
$10.07M
|
$11.13M
|
|
Net Cash Flow
|
$-79.93M
|
$-29.2M
|
$7.73M
|
|
PE Ratio
|
|
|
|
|
|
|